Company profile
PYC Therapeutics company profile
PYC Therapeutics is a clinical-stage biotechnology company specializing in RNA-based therapies targeting genetic diseases. It leverages a proprietary delivery system using cell‑penetrating peptides (CPPs) conjugated to phosphorodiamidate morpholino oligomers (PMOs) to enhance cellular uptake. The company’s pipeline focuses on inherited conditions affecting the eye, central nervous system, and kidney, including ongoing Phase 1 and natural history studies.
Business identity
- Website
- http://www.pyctx.com/
- Contact email
- [email protected]
- Phone number
- +61 8 6151 0992
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $50,000+
- Founded
- 2005-01-01, Year
Headquarters
- Headquarters
- Nedlands, Western Australia, Australia
- Postal code
- 6009
- Country code
- AU
- Continent
- Oceania